Hydroxyethyl Starch (HES) [130/0.4], a New HES Specification: Pharmacokinetics and Safety after Multiple Infusions of 10% Solution in Healthy Volunteers

By Waitzinger J.  

Drugs in R&D, Vol. 4, Iss. 3, 2003-01 ,pp. : 149-157

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Tolerability of a New Hydroxyethyl Starch (HES) Specification [HES (130/0.4)] after Single-Dose Infusion of 6% or 10% Solutions in Healthy Volunteers

By Waitzinger J.  

Clinical Drug Investigation, Vol. 16, Iss. 2, 1998-08 ,pp. : 151-160

Adis International

Access to resources Recommend Favorite

Bioequivalence Comparison between Hydroxyethyl Starch 130/0.42/6 : 1 and Hydroxyethyl Starch 130/0.4/9 : 1

By Lehmann G.  

Drugs in R&D, Vol. 8, Iss. 4, 2007-01 ,pp. : 229-240

Adis International

Access to resources Recommend Favorite

Effect of Molecular Weight and Substitution on Tissue Uptake of Hydroxyethyl Starch: A Meta-Analysis of Clinical Studies

By Bellmann Romuald  

Clinical Pharmacokinetics, Vol. 51, Iss. 4, 2012-04 ,pp. : 225-236

Adis International

Access to resources Recommend Favorite

Tissue Storage of 14 C-Labelled Hydroxyethyl Starch (HES) 130/0.4 and HES 200/0.5 after Repeated Intravenous Administration to Rats

By Leuschner J.  

Drugs in R&D, Vol. 4, Iss. 6, 2003-01 ,pp. : 331-338

Adis International

Access to resources Recommend Favorite